Skip to main content

Pickett C Taylor's Form 4/A amendment

Amended

Omega Healthcare Investors IncOHI · filed Jan 12, 2026

Accession no.
0001143567-26-000008
Filed
Jan 12, 2026
Trade date
Dec 30, 2025
Filing delay
13 days
Rule 10b5-1 plan
Not checked
Original filed
Jan 2, 2026

This filing lists 1 derivative transaction. It carries over 6 transactions from the original filing that it did not restate. It was filed 13 days after the trade.

This amendment restates part of 0001143567-26-000002 (filed Jan 2, 2026). The transactions it did not restate still count and are listed below.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Pickett C TaylorCIK 0001143567Director, Officer (CHIEF EXECUTIVE OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

This filing has no transactions of this kind.

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 30, 2025Common StockSSaleDisposed−200,000$0.00$0934,750Direct

Carried over from the original filing

This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.

From 0001143567-26-000002 (filed Jan 2, 2026).

Derivative securities (Table II)

Derivative transactions carried over from 0001143567-26-000002
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 31, 2025OP UnitsMOption exerciseDisposed−60,459$0.00$0265,425Direct
Dec 31, 2025OP UnitsMOption exerciseDisposed−62,622$0.00$0202,803Direct
Dec 31, 2025OP UnitsMOption exerciseDisposed−71,770$0.00$0131,033Direct
Dec 31, 2025Common StockMOption exerciseAcquired+60,459$0.00$0995,209Direct
Dec 31, 2025Common StockMOption exerciseAcquired+62,622$0.00$01,057,831Direct
Dec 31, 2025Common StockMOption exerciseAcquired+71,770$0.00$01,129,601Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The reporting person redeemed 200,000 units of limited partnership interest (each, an "OP Unit") in OHI Healthcare Properties Limited Partnership, of which Omega Healthcare Investors, Inc. (the "Company") is the general partner. Each OP Unit was redeemed for an amount of cash equal to the average of the daily closing price of the Company's common stock on the New York Stock Exchange for the 10 consecutive trading days immediately preceding the Company's receipt of the notice of redemption, or $44.25.

F2

The reporting person's redemption of OP Units herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 20,000 underlying shares, with the reporting person's purchase of 20,000 shares of the Company's common stock on November 5, 2025. The reporting person has paid $22,144.00 to the Company, representing the full amount of profit realized in connection with the short-swing transaction.

F3

Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one (1) share of Issuer common stock, or at the Issuer's election, one (1) share of Issuer common stock, subject to continued employment and accelerated vesting under certain circumstances. The OP Units have no expiration date.

Remarks

Footnote 1 to the Form 4 filed by the reporting person on January 2, 2026 contained a typographical error incorrectly reporting the average of the daily closing price of the Company's common stock on the New York Stock Exchange for the 10 consecutive trading days immediately preceding the Company's receipt of the notice of redemption. The redemption price paid to the reporting person and the short-swing profit paid to the Company as of December 30, 2025 were based on the actual average trading price of $44.25 per share. The line item in Table II of this Amendment to Form 4 is repeated from the Original Form 4 only to gain access to the filing system. Other than the information added by this Amendment to Form 4, the Original Form 4, including footnotes, is unchanged.

Read the full filing on SEC EDGAR (opens in a new tab)